1-4 of 4
Scott Cruickshank
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.

Ravi Vij, MD, Luhua Wang, MD, Robert Z Orlowski, M.D., Ph.D., A. Keith Stewart, MD, Sundar Jagannath, MD, Sagar Lonial, MD, Suzanne Trudel, MD, Andrzej J Jakubowiak, MD, PhD, Andrew Belch, MD, Melissa Alsina, MD, Nizar J Bahlis, MD, Mai H. Le, MD, Scott Cruickshank, BA, MS, Mark K Bennett, PhD, Susan Molineaux, PhD, Michael Kauffman, MD, PhD, David Siegel, MD, The Multiple Myeloma Research Consortium (MMRC)
Journal: Blood
Blood (2009) 114 (22): 430.
https://doi.org/10.1182/blood.V114.22.430.430
Published: 2009
Journal Articles

Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Studyof Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma (MM)

Sundar Jagannath, MD, Ravi Vij, MD, A. Keith Stewart, MBChB, George Somlo, MD, Andrzej Jakubowiak, MD, PhD, Tony Reiman, MD, Suzanne Trudel, MD, Jessica Taylor, BA, Diana Fuhrman, BSN, Scott Cruickshank, MS, Richard Schwartz, MD, Lori Kunkel, MD, David Siegel, MD, PhD, The Multiple Myeloma Research Consortium (MMRC)
Journal: Blood
Blood (2008) 112 (11): 864.
https://doi.org/10.1182/blood.V112.11.864.864
Published: 2008
Journal Articles

Initial Results of PX-171-004, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM)

Ravi Vij, MD, Michael Wang, MD, Robert Orlowski, MD, PhD, A. Keith Stewart, MBChB, Sundar Jagannath, MD, Vishal Kukreti, MD, FRCPC, Jessica Taylor, BA, Diana Fuhrman, BSN, Scott Cruickshank, MS, Richard Schwartz, MD, Lori Kunkel, MD, David Siegel, MD, PhD, The Multiple Myeloma Research Consortium (MMRC)
Journal: Blood
Blood (2008) 112 (11): 865.
https://doi.org/10.1182/blood.V112.11.865.865
Published: 2008
Journal Articles

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease

Clinical Trials & Observations
David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Ted Gooley, Friedrich Schuening, Scott Rowley, Donald David, Mark Brunvand, Brian Berryman, Sunil Abhyankar, Michelle Bouvier, George B. McDonald, for the orBec GVHD Study Group
Journal: Blood
Blood (2007) 109 (10): 4557–4563.
https://doi.org/10.1182/blood-2006-05-021139
Published: 2007
Includes: Supplemental data